Hoon; Dave S. B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hoon; Dave S. B..The latest application filed is for "collector for detection and reversible capturing of cells from body fluids in vivo".

Company Profile

1.22.59

Hoon; Dave S. B. - Santa Monica CA
Hoon; Dave S. B. - Los Angeles CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Collector for detection and reversible capturing of cells from body fluids in vivo Grant 11,160,542 - Hoon November 2, 2	2021-11-02
Collector For Detection And Reversible Capturing Of Cells From Body Fluids In Vivo App 20170354400 - Hoon; Dave S.B.	2017-12-14
Molecular malignancy in melanocytic lesions Grant 9,758,829 - Wang , et al. September 12, 2	2017-09-12
Utility of B-RAF DNA mutation in diagnosis and treatment of cancer Grant 9,567,640 - Hoon February 14, 2	2017-02-14
Utility of B-RAF DNA mutation in diagnosis and treatment of cancer Grant 9,556,491 - Hoon January 31, 2	2017-01-31
Long noncoding RNA (lncRNA) as a biomarker and therapeutic marker in cancer Grant 9,410,206 - Hoon , et al. August 9, 2	2016-08-09
Use Of Id4 For Diagnosis And Treatment Of Cancer App 20160122826 - Hoon; Dave S.B. ; et al.	2016-05-05
Use Of Free Circulating Dna For Diagnosis, Prognosis, And Treatment Of Cancer App 20160115547 - Hoon; Dave S.B. ; et al.	2016-04-28
B7-h3 As A Biomarker For Diagnosing The Progression And Early Lymph Node Metastasis Of Cancer App 20150301059 - Hoon; Dave S.B.	2015-10-22
Use Of Methylated Or Unmethylated Line-1 Dna As A Cancer Marker App 20150240316 - Hoon; Dave S.B. ; et al.	2015-08-27
Molecular Malignancy In Melanocytic Lesions App 20150176072 - Wang; Hui ; et al.	2015-06-25
Immunological Markers For Adjuvant Therapy In Melanoma App 20150140039 - Hoon; Dave S.B. ; et al.	2015-05-21
Use of ID4 for Diagnosis and Treatment of Cancer App 20130345144 - Hoon; Dave S. B. ; et al.	2013-12-26
Direct Blood Assay For Detection Of Circulating Microrna In Cancer Patients App 20130323740 - Hoon; Dave S.B. ; et al.	2013-12-05
Detection of Micro Metastasis of Melanoma and Breast Cancer in Paraffin-Embedded Tumor Draining Lymph Nodes by Multimarker Quantitative RT-PCR App 20130231259 - Hoon; Dave S.B. ; et al.	2013-09-05
Long Noncoding Rna (lncrna) As A Biomarker And Therapeutic Marker In Cancer App 20130178428 - Hoon; Dave S.B. ; et al.	2013-07-11
USE OF CCR9, CCL25/TECK, AND INTEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE App 20120301477 - Hoon; Dave S.B. ; et al.	2012-11-29
Utility Of B-raf Dna Mutation In Diagnosis And Treatment Of Cancer App 20120295258 - Hoon; Dave S.B.	2012-11-22
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer Grant 8,288,099 - Hoon , et al. October 16, 2	2012-10-16
Use Of Runx3 And Mir-532-5p As Cancer Markers And Therapeutic Targets App 20120148561 - Hoon; Dave S.B. ; et al.	2012-06-14
Detection of Cancer Cells in Body Fluids App 20120088683 - Hoon; Dave S. B.	2012-04-12
Detection of cancer cells in body fluids Grant 8,039,218 - Hoon October 18, 2	2011-10-18
Use Of Methylation Status Of Mint Loci And Tumor Related Genes As A Marker For Melanoma And Breast Cancer App 20110212444 - Hoon; Dave S.B. ; et al.	2011-09-01
Detection of Micro Metastasis of Melanoma and Breast Cancer in Paraffin-Embedded Tumor Draining Lymph Nodes by Multimarker Quantitative RT-PCR App 20110207136 - Hoon; Dave S. B. ; et al.	2011-08-25
B7-h3 As A Biomarker For Diagnosing The Progression And Early Lymph Node Metastasis Of Cancer App 20110206705 - HOON; Dave S.B.	2011-08-25
Utility Of Ret Mutant In Diagnosis And Treatment Of Melanoma App 20110195499 - HOON; DAVE S.B. ; et al.	2011-08-11
Use Of Ccr9, Ccl25/teck, And Integrin Alpha4 In Diagnosis And Treatment Of Melanoma Metastasis In The Small Intestine App 20110171660 - Hoon; Dave S. B. ; et al.	2011-07-14
Use Of Ccr9, Ccl25/teck, And Integrin Alpha4 In Diagnosis And Treatment Of Melanoma Metastasis In The Small Intestine App 20110171240 - Hoon; Dave S. B. ; et al.	2011-07-14
Loss Of Heterozygosity Of The Dna Markers In The 12q22-23 Region App 20110171632 - FUJIMOTO; Akihide ; et al.	2011-07-14
Use Of Methylated Or Unmethylated Line-1 Dna As A Cancer Marker App 20110159501 - Hoon; Dave S.B. ; et al.	2011-06-30
Use Of Runx3 And Mir-532-5p As Cancer Markers And Therapeutic Targets App 20110159509 - Hoon; Dave S.B. ; et al.	2011-06-30
Use Of Methylated Or Unmethylated Line-1 Dna As A Cancer Marker App 20110159510 - Hoon; Dave S.B. ; et al.	2011-06-30
Use Of Runx3 And Mir-532-5p As Cancer Markers And Therapeutic Targets App 20110158975 - Hoon; Dave S.B. ; et al.	2011-06-30
Use Of Methylated Or Unmethylated Line-1 Dna As A Cancer Marker App 20110159502 - Hoon; Dave S.B. ; et al.	2011-06-30
Use Of Methylated Or Unmethylated Line-1 Dna As A Cancer Marker App 20110151465 - Hoon; Dave S.B. ; et al.	2011-06-23
Molecular Lymphatic Mapping Of Sentinel Lymph Nodes App 20110123602 - Hoon; Dave S.B. ; et al.	2011-05-26
Utility Of High Molecular Weight Melanoma Associated Antigen In Diagnosis And Treatment Of Cancer App 20110124007 - Hoon; Dave S.B. ; et al.	2011-05-26
Utility Of High Molecular Weight Melanoma Associated Antigen In Diagnosis And Treatment Of Cancer App 20110124004 - Hoon; Dave S.B. ; et al.	2011-05-26
Utility of RET mutant in diagnosis and treatment of melanoma Grant 7,943,319 - Hoon , et al. May 17, 2	2011-05-17
Dna Markers For Management Of Cancer App 20110097727 - HOON; Dave S.B. ; et al.	2011-04-28
Use Of Id4 For Diagnosis And Treatment Of Cancer App 20110098341 - Hoon; Dave S.B. ; et al.	2011-04-28
Methylation Of Estrogen Receptor Alpha And Uses Thereof App 20110091970 - Hoon; Dave S.B.	2011-04-21
Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimarker quantitative RT-PCR Grant 7,910,295 - Hoon , et al. March 22, 2	2011-03-22
Molecular lymphatic mapping of sentinel lymph nodes Grant 7,897,336 - Hoon , et al. March 1, 2	2011-03-01
Use of ID4 for diagnosis and treatment of cancer Grant 7,888,033 - Hoon , et al. February 15, 2	2011-02-15
Dna Markers For Management Of Cancer App 20100330567 - Hoon; Dave S.B. ; et al.	2010-12-30
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer Grant 7,851,161 - Hoon , et al. December 14, 2	2010-12-14
Epigenetic Silencing of Cyclooxygenase-2 Affects Clinical Outcome in Gastric Cancer App 20100304376 - Hoon; Dave S.B. ; et al.	2010-12-02
Methylation of estrogen receptor alpha and uses thereof Grant 7,829,283 - Hoon November 9, 2	2010-11-09
Use Of Runx3 And Mir-532-5p As Cancer Markers And Therapeutic Targets App 20100227319 - Hoon; Dave S.B. ; et al.	2010-09-09
DNA markers for management of cancer Grant 7,718,364 - Hoon , et al. May 18, 2	2010-05-18
Use of Methylation Status of MINT Loci as a Marker for Rectal Cancer App 20100003689 - HOON; Dave S. B. ; et al.	2010-01-07
Use Of Free Circulating Dna For Diagnosis, Prognosis, And Treatment Of Cancer Funding App 20090280479 - Hoon; Dave S.B. ; et al.	2009-11-12
Use Of Id4 For Diagnosis And Treatment Of Cancer App 20090263812 - Hoon; Dave S.B. ; et al.	2009-10-22
Use of ID4 for diagnosis and treatment of cancer Grant 7,588,894 - Hoon , et al. September 15, 2	2009-09-15
Use Of Methylation Status Of Mint Loci And Tumor-related Genes As A Marker For Melanoma And Breast Cancer App 20090220980 - Hoon; Dave S.B. ; et al.	2009-09-03
Utility Of Ret Mutant In Diagnosis And Treatment Of Melanoma App 20090208952 - Hoon; Dave S.B. ; et al.	2009-08-20
Use Of Methylated Or Unmethylated Line-1 Dna As A Cancer Marker App 20090068660 - Hoon; Dave S.B. ; et al.	2009-03-12
Epigenetic Silencing Of Cyclooxygenase-2 Affects Clinical Outcome In Gastric Cancer App 20090061441 - HOON; Dave S.B. ; et al.	2009-03-05
USE OF CCR9, CCL25/TECK, AND NITEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE App 20090028866 - Hoon; Dave S.B. ; et al.	2009-01-29
Functional Toll-like Receptors (tlr) On Melanocytes And Melanoma Cells And Uses Thereof App 20090011418 - HOON; Dave S.B. ; et al.	2009-01-08
Methylation Of Estrogen Receptor Alpha And Uses Thereof App 20080299551 - Hoon; Dave S.B.	2008-12-04
Utility Of B-raf Dna Mutation In Diagnosis And Treatment Of Cancer App 20080268449 - HOON; Dave S.B.	2008-10-30
Utility Of High Molecular Weight Melanoma Associated Antigen In Diagnosis And Treatment Of Cancer App 20080076727 - Hoon; Dave S.B. ; et al.	2008-03-27
Molecular/genetic aberrations in surgical margins of resected pancreatic cancer represents neoplastic disease that correlates with disease outcome App 20070031867 - Hoon; Dave S.B. ; et al.	2007-02-08
Use of ID4 for diagnosis and treatment of cancer App 20070020646 - Hoon; Dave S. B. ; et al.	2007-01-25
Detection of cancer cells in body fluids App 20060115832 - Hoon; Dave S. B.	2006-06-01
DNA markers for management of cancer App 20060051768 - Hoon; Dave S.B. ; et al.	2006-03-09
Molecular lymphatic mapping of sentinel lymph nodes App 20050142556 - Hoon, Dave S.B. ; et al.	2005-06-30
Loss of heterozygosity of the DNA markers in the 12q22-23 region App 20050112604 - Fujimoto, Akihide ; et al.	2005-05-26
Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimarker quantitative RT-PCR App 20040265845 - Hoon, Dave S.B. ; et al.	2004-12-30
DNA vaccine and methods for its use Grant 6,472,375 - Hoon , et al. October 29, 2	2002-10-29
Detection of loss of heterozygosity in tumor and serum of melanoma patients Grant 6,465,177 - Hoon October 15, 2	2002-10-15
RNA cancer vaccine and methods for its use Grant 6,432,925 - Hoon , et al. August 13, 2	2002-08-13
Detection of melanoma or breast metastasis with a multiple marker assay Grant 6,057,105 - Hoon , et al. May 2, 2	2000-05-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.